Your shopping cart is currently empty

SJ1008030 (compound 8) TFA is a selective JAK2-degrading PROTAC that inhibits the growth of MHH-CALL-4 leukemia cells with an IC50 of 5.4 nM, demonstrating its potential for leukemia research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SJ1008030 (compound 8) TFA is a selective JAK2-degrading PROTAC that inhibits the growth of MHH-CALL-4 leukemia cells with an IC50 of 5.4 nM, demonstrating its potential for leukemia research [1]. |
| In vitro | SJ1008030 (compound 8) exhibited activity in CRLF2r cell line (MHH-CALL-4) with an IC50 of 5.4 nM after 72-hour treatment with TFA [1]. Dose-dependent degradation of JAK, GSPT1, and IKZF1 was observed in MHH-CALL-4 cells treated with SJ1008030 (0-4.3 μM; 72 hours) TFA [1]. Additionally, SJ1008030 (0-10 μM; 24h) TFA dose-dependently degraded JAK2 and GSPT1 proteins in xenografted bone marrow cells SJBALL021415, indicating inhibition of the JAK-STAT signaling pathway [1]. |
| Molecular Weight | 987.96 |
| Formula | C44H44F3N13O9S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.